Hyperledger Fabric (HLF) is an open-source platform for deploying enterprise-level permissioned blockchains where users from multiple organizations can participate. Preventing unauthorized access to resources in such blockchains is of critical importance. Towards addressing this requirement, HLF supports different access control models. However, support for Attribute-Based Access Control (ABAC) in the current version of HLF is not comprehensive enough to address various requirements that arise when multiple organizations interact in an enterprise setting. To address those shortcomings, in this paper, we develop and present methods for providing full ABAC functionality in Hyperledger Fabric. Performance evaluation under different network configurations using the Hyperledger Caliper benchmarking tool shows that the proposed approach is quite efficient in practice.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762829PMC
http://dx.doi.org/10.1007/978-3-031-06975-8_21DOI Listing

Publication Analysis

Top Keywords

access control
12
hyperledger fabric
12
attribute-based access
8
multiple organizations
8
supporting attribute-based
4
access
4
hyperledger
4
control hyperledger
4
fabric blockchain
4
blockchain hyperledger
4

Similar Publications

Pea plants depend on external structures to reach the strongest light source. To do this, they need to perceive a potential support and to flexibly adapt the movement of their motile organs (e.g.

View Article and Find Full Text PDF

Primary esophageal melanoma (PEM) is a rare and aggressive malignancy with limited treatment options. Due to its rarity, no standardized guidelines exist for managing oligometastatic recurrence, particularly in resource-limited settings. We present a case of a 60-year-old male with PEM who underwent esophagectomy followed by surgical resection of an adrenal metastasis.

View Article and Find Full Text PDF

From the Masterclasses in Dermatology 2024 Meeting: Updates in Psoriasis Treatments.

J Clin Aesthet Dermatol

February 2025

Ms. Romanelli and Dr. Gottlieb are with the Department of Dermatology and Department of Medicine, Division of Rheumatology at Icahn School of Medicine at Mount Sinai in New York, New York.

Psoriasis (PsO) is an immune-mediated, chronic inflammatory skin disease that significantly impairs quality of life. Its treatment landscape is rapidly evolving, providing better disease control. Here, we highlight updates in biologics, obtaining coverage for biologics under Medicare, the PsO-to-psoriatic arthritis (PsA) transition, and orally administered drugs, as presented at the 2024 Masterclass in Dermatology in Puerto Rico.

View Article and Find Full Text PDF

Background: Pediatric dentists employ both pharmacological and non-pharmacological behavior control methods. Despite the use of behavioral control techniques, some young children cannot undergo treatment in the office, making sedation or general anesthesia necessary. Premedication drugs can be used before general anesthesia to reduce anxiety, control pain, induce amnesia, prevent nausea, and avert potential complications.

View Article and Find Full Text PDF

Background: Cardiovascular diseases (CVDs) are a major global health concern, with their prevalence rising significantly in developing regions like South India. This increase is driven by unique dietary patterns, lifestyle habits, and genetic predispositions contributing to the region's distinct cardiovascular risk profile. However, gaps remain in understanding the biochemical risk factors specific to this population.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!